Immunopharmacological Effects of Rituximab in Atopic Dermatitis

Clinical trial NCT00267826 · COMPLETED

Trial details

NCT number: NCT00267826
Sponsor: University of Bern
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Dermatitis, Atopic

Start date: 2005-12-01
Primary completion: 2006-06-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.